DLH Wins Follow-On Contract for CMOP Medical Logistics for the Department of Veterans Affairs
April 23 2021 - 8:00AM
DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the
“Company”), a leading provider of innovative healthcare
research, services and solutions to federal agencies, today
announced that it has been awarded a follow-on contract to provide
medical logistics to the Department of Veterans Affairs (“VA”)
Consolidated Mail Outpatient Pharmacy (“CMOP”). The contract
includes a base period of one year, with four one-year options, for
a total value of $202 million. This award completes the procurement
process under which the VA initially evaluated proposals from
various tiers of small businesses for potentially awarding a
set-aside contract. Ultimately, the VA removed all other set-aside
tiers from consideration and evaluated proposals from the large
business tier in making its award to DLH.
“Our 20-year relationship with the VA is a
tremendous source of pride for our company,” said Kevin Wilson,
President of DLH’s Health & Logistics Services operating unit.
“The COVID-19 pandemic demonstrated the indispensable value of mail
order as an additional care tool, and DLH is thrilled to continue
in the development of innovative health solutions.”
The contract leverages DLH’s medical logistics
expertise with highly automated processing facilities and
innovative delivery systems, using advanced analytics and
statistical algorithms, to assist in the seamless delivery of
pharmaceuticals to veterans. The CMOP program functions as a
virtual extension of the Veterans Affairs Medical Center
pharmacies. The program processed over 120 million prescriptions
last year from seven geographical locations nationwide supporting
our nation’s veterans.
“DLH is honored to continue our support of the
VA’s CMOP program in its mission to ensure millions of veterans
receive their vital prescription medications on time,” said Zach
Parker, President & CEO of DLH. “Our medical logistics experts
utilize innovative technology and advanced processes to improve
productivity and lower costs for our customer – maximizing the
resources available for veterans.”
About DLHDLH delivers improved
health and readiness solutions for federal programs through
research, development, and innovative care processes. The Company’s
experts in public health, performance evaluation, and health
operations solve the complex problems faced by civilian and
military customers alike, leveraging digital transformation,
artificial intelligence, advanced analytics, cloud-based
applications, telehealth systems, and more. With over 2,200
employees dedicated to the idea that “Your Mission is Our Passion,”
DLH brings a unique combination of government sector experience,
proven methodology, and unwavering commitment to public health to
improve the lives of millions. For more information, visit
www.DLHcorp.com.
Safe Harbor Statement under the Private
Securities Litigation Reform Act of 1995:This press
release may contain forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995. These
statements relate to future events or DLH`s future financial
performance. Any statements that refer to expectations, projections
or other characterizations of future events or circumstances or
that are not statements of historical fact (including without
limitation statements to the effect that the Company or its
management “believes”, “expects”, “anticipates”, “plans”, “intends”
and similar expressions) should be considered forward looking
statements that involve risks and uncertainties which could cause
actual events or DLH’s actual results to differ materially from
those indicated by the forward-looking statements. Forward-looking
statements in this release include, among others, statements
regarding estimates of future revenues. These statements reflect
our belief and assumptions as to future events that may not prove
to be accurate. Our actual results may differ materially from such
forward-looking statements made in this release due to a variety of
factors, including: the outbreak of the novel coronavirus
(“COVID-19”), including the measures to reduce its spread, and its
impact on the economy and demand for our services, are uncertain,
cannot be predicted, and may precipitate or exacerbate other risks
and uncertainties; the risk that we will not realize the
anticipated benefits of our recent or any future acquisition; the
challenges of managing larger and more widespread operations
resulting from the acquisition; contract awards in connection with
re-competes for present business and/or competition for new
business; compliance with new bank financial and other covenants;
changes in client budgetary priorities; government contract
procurement (such as bid protest, small business set asides, loss
of work due to organizational conflicts of interest, etc.) and
termination risks; the ability to successfully integrate the
operations of our recent acquisition and any future acquisitions;
and other risks described in our SEC filings. For a discussion of
such risks and uncertainties which could cause actual results to
differ from those contained in the forward-looking statements, see
“Risk Factors” in the Company’s periodic reports filed with the
SEC, including our Annual Report on Form 10-K for the fiscal year
ended September 30, 2020, as well as subsequent reports filed
thereafter. The forward-looking statements contained herein are not
historical facts, but rather are based on current expectations,
estimates, assumptions and projections about our industry and
business. Such forward-looking statements are made as of the date
hereof and may become outdated over time. The Company does not
assume any responsibility for updating forward-looking statements,
except as may be required by law.
CONTACTS:
INVESTOR RELATIONSContact: Chris WittyPhone:
646-438-9385Email: cwitty@darrowir.com
DLH (NASDAQ:DLHC)
Historical Stock Chart
From Aug 2024 to Sep 2024
DLH (NASDAQ:DLHC)
Historical Stock Chart
From Sep 2023 to Sep 2024